Adapalene-Benzoy Peroxide (BPO) Gel in the Treatment of Acne Vulgaris as a 6-month Maintenance
Public ClinicalTrials.gov record NCT00687908. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Efficacy and Safety Comparison of Adapalene 0.1% / Benzoyl Peroxide 2.5% Gel Versus Adapalene 0.1% / Benzoyl Peroxide 2.5% Gel Vehicle Gel as a 6-month Acne Maintenance Treatment
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to demonstrate the efficacy of Adapalene 0.1% /Benzoyl Peroxide 2.5% Gel compared to its Vehicle Gel as an acne maintenance treatment in Subjects previously treated with Adapalene-BPO Gel or Adapalene-BPO Vehicle Gel both associated with Doxycycline Hyclate 100 mg. The safety of the two investigational treatments will also be assessed.
Study identification
- NCT ID
- NCT00687908
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 243 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 12 Years to 35 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Nov 2008 (Type not available)
- Primary completion
- Jul 2009 (Actual)
- Completion
- Jul 2009 (Actual)
- Last update posted
- Feb 18, 2021
2008 – 2009
United States locations
- U.S. sites
- 27
- U.S. states
- 18
- U.S. cities
- 27
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Galderma Investigational Site | San Diego | California | — | — |
| Galderma Investigational Site | Denver | Colorado | — | — |
| Galderma Investigational Site | Longmont | Colorado | — | — |
| Galderma Investigational Site | Miami | Florida | — | — |
| Galderma Investigational Site | Snellville | Georgia | — | — |
| Galderma Investigational Site | Chicago | Illinois | — | — |
| Galderma Investigational Site | Evansville | Indiana | — | — |
| Galderma Investigational Site | Overland Park | Kansas | — | — |
| Galderma Investigational Site | Louisville | Kentucky | — | — |
| Galderma Investigational Site | Detroit | Michigan | — | — |
| Galderma Investigational Site | Fort Gratiot | Michigan | — | — |
| Galderma Investigational Site | Fridley | Minnesota | — | — |
| Galderma Investigational Site | Omaha | Nebraska | — | — |
| Galderma Investigational Site | Albuquerque | New Mexico | — | — |
| Galderma Investigational Site | Stony Brook | New York | — | — |
| Galderma Investigational Site | Winston-Salem | North Carolina | — | — |
| Galderma Investigational Site | Warren | Ohio | — | — |
| Galderma Investigational Site | Hazleton | Pennsylvania | — | — |
| Galderma Investigational Site | Hershey | Pennsylvania | — | — |
| Galderma Investigational Site | Simpsonville | South Carolina | — | — |
| Galderma Investigational Site | Arlington | Texas | — | — |
| Galderma Investigational Site | Austin | Texas | — | — |
| Galderma Investigational Site | College Station | Texas | — | — |
| Galderma Investigational Site | Houston | Texas | — | — |
| Galderma Investigational Site | Lubbock | Texas | — | — |
| Galderma Investigational Site | San Antonio | Texas | — | — |
| Galderma Investigational Site | Webster | Texas | 77598 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 6 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00687908, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Feb 18, 2021 · Synced Oct 20, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00687908 live on ClinicalTrials.gov.